Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Geracioti, T. D. Articles by Kasckow, J. W. Search for Related Content PubMed Citation Articles by Geracioti, T. D., Jr. Articles by Kasckow, J. W. Neuroendocrinology Neurotransmitters Posttraumatic Stress Disorder

CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder

OBJECTIVE: Despite evidence of hyperresponsive peripheral and central nervous system (CNS) noradrenergic activity in posttraumatic stress disorder (PTSD), direct measures of CNS norepinephrine in PTSD have been lacking. The goal of this study was to determine serial CSF norepinephrine levels in patients with PTSD. METHOD: CSF samples were obtained serially over a 6-hour period in 11 male combat veterans with chronic PTSD and eight healthy men through an indwelling subarachnoid catheter. Thus the authors were able to determine hourly CSF norepinephrine concentrations under baseline (unstressed) conditions. Severity of the patients’ PTSD symptoms was assessed with the Clinician-Administered PTSD Scale. RESULTS: CSF norepinephrine concentrations were significantly higher in the men with PTSD than in the healthy men. Moreover, CSF norepinephrine levels strongly and positively correlated with the severity of PTSD symptoms. Plasma norepinephrine concentrations showed no significant relationship with the severity of PTSD symptoms. CONCLUSIONS: These findings reveal the presence of greater CNS noradrenergic activity under baseline conditions in patients with chronic PTSD than in healthy subjects and directly link this pathophysiologic observation with the severity of the clinical posttraumatic stress syndrome.

This article has been cited by other articles:

				D. Mueller, J. T. Porter, and G. J. Quirk Noradrenergic Signaling in Infralimbic Cortex Increases Cell Excitability and Strengthens Memory for Fear Extinction J. Neurosci., January 9, 2008; 28(2): 369 - 375. [Abstract] [Full Text] [PDF]

				A. F. T. Arnsten Catecholamine and Second Messenger Influences on Prefrontal Cortical Networks of "Representational Knowledge": A Rational Bridge between Genetics and the Symptoms of Mental Illness Cereb Cortex, September 1, 2007; 17(suppl_1): i6 - i15. [Abstract] [Full Text] [PDF]

				E. A. Keram Commentary: The Zone of Danger, Physical Impact, and PTSD J Am Acad Psychiatry Law, June 1, 2006; 34(2): 200 - 203. [Abstract] [Full Text] [PDF]

				T. D. Geracioti Jr., L. L. Carpenter, M. J. Owens, D. G. Baker, N. N. Ekhator, P. S. Horn, J. R. Strawn, G. Sanacora, B. Kinkead, L. H. Price, et al. Elevated Cerebrospinal Fluid Substance P Concentrations in Posttraumatic Stress Disorder and Major Depression Am J Psychiatry, April 1, 2006; 163(4): 637 - 643. [Abstract] [Full Text] [PDF]

				H. S. Bracha, E. Garcia-Rill, R. E. Mrak, and R. Skinner Postmortem Locus Coeruleus Neuron Count in Three American Veterans With Probable or Possible War-Related PTSD J Neuropsychiatry Clin Neurosci, November 1, 2005; 17(4): 503 - 509. [Abstract] [Full Text] [PDF]

				J. R. Strawn, N. N. Ekhator, P. S. Horn, D. G. Baker, and T. D. Geracioti Jr. Blood Pressure and Cerebrospinal Fluid Norepinephrine in Combat-Related Posttraumatic Stress Disorder Psychosom Med, September 1, 2004; 66(5): 757 - 759. [Abstract] [Full Text] [PDF]

				N. Herrmann, K. L. Lanctot, and L. R. Khan The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 261 - 276. [Abstract] [Full Text] [PDF]

				D. S. Charney Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress Focus, July 1, 2004; 2(3): 368 - 391. [Abstract] [Full Text] [PDF]

				D. S. Charney Psychobiological Mechanisms of Resilience and Vulnerability: Implications for Successful Adaptation to Extreme Stress Am J Psychiatry, February 1, 2004; 161(2): 195 - 216. [Abstract] [Full Text] [PDF]

				C. L. Raison and A. H. Miller When Not Enough Is Too Much: The Role of Insufficient Glucocorticoid Signaling in the Pathophysiology of Stress-Related Disorders Am J Psychiatry, September 1, 2003; 160(9): 1554 - 1565. [Abstract] [Full Text] [PDF]

				E. R. Peskind, L. T. Bonner, D. J. Hoff, and M. A. Raskind Prazosin Reduces Trauma-Related Nightmares in Older Men with Chronic Posttraumatic Stress Disorder J Geriatr Psychiatry Neurol, September 1, 2003; 16(3): 165 - 171. [Abstract] [PDF]

				M. A. Raskind, E. R. Peskind, E. D. Kanter, E. C. Petrie, A. Radant, C. E. Thompson, D. J. Dobie, D. Hoff, R. J. Rein, K. Straits-Troster, et al. Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study Am J Psychiatry, February 1, 2003; 160(2): 371 - 373. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us